Noninfectious Environmental Agents and Autoimmunity

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 297,X-307,X

  Miller, Frederick W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78549280314     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50026-3     Document Type: Chapter

References (61)

1. Advisory Committee on Immunization Practices (1996) Update: Vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 45 1-35.
2. A. Alaedini and P.H. Green (2005) Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann. Intern. Med. 142 289-298.
3. M.R. Arbuckle, M.T. McClain, M.V. Rubertone, R.H. Scofield, G.J. Dennis, J.A. James and J.B. Harley (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 1526-1533.
4. C.M. Artlett, R. Ramos, S.A. Jiminez, K. Patterson, F.W. Miller and L.G. Rider (2000) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 356 2155-2156.
5. L.M. Bagenstose, P. Salgame and M. Monestier (1999) Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol. Res. 20 67-78.
6. P.E. Bigazzi (1994) Autoimmunity and heavy metals. Lupus 3 449-453.
7. P.E. Bigazzi (1997) Autoimmunity caused by xenobiotics. Toxicology 119 1-21.
8. S.L. Brown (2002) Epidemiology of silicone-gel breast implants. Epidemiology 13(Suppl.), S34-S39.
9. S.L. Brown, J.J. Langone and L.A. Brinton (1998) Silicone breast implants and autoimmune disease. J. Am. Med. Womens Assoc. 53(21–24), 40.
10. G.S. Cooper, F.W. Miller and D.R. Germolec (2002) Occupational exposures and autoimmune diseases. Int. Immunopharmacol. 2 303-313.
11. G.S. Cooper, F.W. Miller and J.P. Pandey (1999) The role of genetic factors in autoimmune disease: Implications for environmental research. Environ. Health Perspect. 107(Suppl), 693-700.
12. G.S. Cooper and B.C. Stroehla (2003) The epidemiology of autoimmune diseases. Autoimmun. Rev. 2 119-125.
13. J. Cukier, R.A. Beauchamp, J.S. Spindler, S. Spindler, C. Lorenzo and D.E. Trentham (1993) Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann. Int. Med. 118 920-928.
14. D. D'Cruz (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. 112–113 421-432.
15. G. Dahlquist (1998) The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr 425(Suppl), 5-10.
16. A. Dally (1997) The rise and fall of pink disease. Soc. Hist. Med. 10 291-304.
17. I.J. Elenkov and G.P. Chrousos (1999) Stress, cytokine patterns and susceptibility to disease. Baillières Best Pract. Res. Clin. Endocrinol. Metab 13 583-595.
18. A.P. Fontenot and B.L. Kotzin (2003) Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity. Tissue Antigens 62 449-458.
19. E. Gelpi, M.P. de la Paz, B. Terracini, I. Abaitua, A.G. de la Camara, E.M. Kilbourne, C. Lahoz, B. Nemery, R.M. Philen, L. Soldevilla and S. Tarkowski (2002) The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge. Environ. Health Perspect. 110 457-464.
20. W.B. Grant (2004) Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the USA. Lupus 13 281-282.
21. E. Haus and M.H. Smolensky (1999) Biologic rhythms in the immune system. Chronobiol. Int. 16 581-622.
22. E.V. Hess (1991) Drug-related lupus. Curr. Opin. Rheumatol. 3 809-814.
23. E.V. Hess (2002) Environmental chemicals and autoimmune disease: cause and effect. Toxicology 181–182 65-70.
24. E.C. Janowsky, L.L. Kupper and B.S. Hulka (2000) Meta-analyses of the relation between silicone breast implants and the risk of connectivetissue diseases. N. Engl. J. Med. 342 781-790.
25. S.A. Khuder, A.Z. Peshimam and S. Agraharam (2002) Environmental risk factors for rheumatoid arthritis. Rev. Environ. Health 17 307-315.
26. E. Krishnan (2003) Smoking, gender and rheumatoid arthritis—epidemiological clues to etiology. Results from the behavioral risk factor surveillance system. Joint Bone Spine 70 496-502.
27. R.L. Leff, S.H. Burgess, F.W. Miller, L.A. Love, I.N. Targoff, M.C. Dalakas, M.M. Joffe and P.H. Plotz (1991) Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 34 1391-1396.
28. D. Leslie, P. Lipsky and A.L. Notkins (2001) Autoantibodies as predictors of disease. J. Clin. Invest. 108 1417-1422.
29. R.D. Leslie and M. Hawa (1994) Twin studies in auto-immune disease. Acta Genet. Med. Gemellol. (Roma) 43 71-81.
30. Z.X. Liu and N. Kaplowitz (2002) Immune-mediated drug-induced liver disease. Clin. Liver Dis. 6 755-774.
31. L.A. Love and F.W. Miller (1993) Noninfectious environmental agents associated with myopathies. Curr. Opin. Rheumatol. 5 712-718.
32. P. Luppi, M.R. Rossiello, S. Faas and M. Trucco (1995) Genetic back-ground and environment contribute synergistically to the onset of autoimmune diseases. J. Mol. Med. 73 381-393.
33. I.R. Mackay (1999) Immunological perspectives on chronic hepatitis: virus infection, autoimmunity and xenobiotics. Hepatogastroenterology 46 3021-3033.
34. F.W. Miller (1999) Genetics of environmentally-associated rheumatic disease. L.D. Kaufman, J. Varga (Eds) Rheumatic Diseases and the Environment London: Arnold 33-45.
35. F.W. Miller, E.V. Hess, D.J. Clauw, P.A. Hertzman, T. Pincus, R.M. Silver, M.D. Mayes, J. Varga, T.A. Medsger Jr. and L.A. Love (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum. 43 243-249.
36. F.W. Miller, K.A. Waite, T. Biswas and P.H. Plotz (1990) The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc. Natl. Acad. Sci. USA. 87 9933-9937.
37. R.J. Nelson and D.L. Drazen (2000) Melatonin mediates seasonal changes in immune function. Ann. N. Y. Acad. Sci. 917 404-415.
38. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez and B.G. Weinshenker (2000) Multiple sclerosis. N. Engl. J. Med. 343 938-952.
39. T. O'Hanlon, B. Koneru, E. Bayat, L. Love, I. Targoff, J. Malley, K. Malley and F. Miller (2004) Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum. 50 3646-3650.
40. C.V. Oddis, C.G. Conte, V.D. Steen and T.A. Medsger Jr. (1990) Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J. Rheumatol. 17 1329-1334.
41. S. Okada, E. Weatherhead, I.N. Targoff, R. Wesley and F.W. Miller (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 48 2285-2293.
42. P. Onkamo, S. Vaananen, M. Karvonen and J. Tuomilehto (1999) Worldwide increase in incidence of Type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42 1395-1403.
43. C.G. Parks, K. Conrad and G.S. Cooper (1999) Occupational exposure to crystalline silica and autoimmune disease. Environ. Health Perspect. 107(Suppl 5), 793-802.
44. A.L. Ponsonby, A. McMichael and I. van der Mei (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181–182 71-78.
45. B. Rowley and M. Monestier (2005) Mechanisms of heavy metal-induced autoimmunity. Mol. Immunol. 42 833-838.
46. U. Samuelsson and J. Carstensen (2003) Space-time clustering at birth and at diagnosis of type 1 diabetes mellitus in relation to early clinical manifestation. J. Pediatr. Endocrinol. Metab. 16 859-867.
47. A. Sarasin (2003) An overview of the mechanisms of mutagenesis and carcinogenesis. Mutat. Res. 544 99-106.
48. K. Sarkar and F.W. Miller (2004) Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun. Rev. 37 291-294.
49. E.A. Shamim and F.W. Miller (2000) Familial autoimmunity and the idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 2 201-211.
50. I.A. Silva, J.F. Nyland, A. Gorman, A. Perisse, A.M. Ventura, E.C. Santos, J.M. de Souza, C.L. Burek, N.R. Rose and E.K. Silbergeld (2004) Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in amazon populations in Brazil: a cross-sectional study. Environ. Health 3 11.
51. P. Stolt, C. Bengtsson, B. Nordmark, S. Lindblad, I. Lundberg, L. Klareskog and L. Alfredsson (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 62 835-841.
52. E.A. Sullivan, M.L. Kamb, J.L. Jones, P. Meyer, R.M. Philen, H. Falk and T. Sinks (1996) The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina. Arch. Intern. Med. 156 973-979.
53. A. Timmer (2003) Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig. Dis. 21 91-104.
54. P. Tugwell, G. Wells, J. Peterson, V. Welch, J. Page, C. Davison, J. McGowan, D. Ramroth and B. Shea (2001) Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum. 44 2477-2484.
55. K.M. Uramoto, C.J. Michet Jr., J. Thumboo, J. Sunku, W.M. O'Fallon and S.E. Gabriel (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum. 42 46-50.
56. N. Ursic-Bratina, T. Battelino, C. Krzisnik, T. Laron-Kenet, I. Ashkenazi and Z. Laron (2001) Seasonality of birth in children (0–14 years) with type 1 diabetes mellitus in Slovenia. J. Pediatr. Endocrinol. Metab. 14 47-52.
57. P. Vestergaard (2002) Smoking and thyroid disorders—a meta-analysis. Eur. J. Endocrinol. 146 153-161.
58. W.J. Williams (1991) Caplan's syndrome. Br. J. Clin. Pract. 45 285-288.
59. J.A. Willis, R.S. Scott, B.A. Darlow, H. Lewy, I. Ashkenazi and Z. Laron (2002) Seasonality of birth and onset of clinical disease in children and adolescents (0–19 years) with type 1 diabetes mellitus in Canterbury, New Zealand. J. Pediatr. Endocrinol. Metab. 15 645-647.
60. B. Winsa, H.O. Adami, R. Bergstrom, A. Gamstedt, P.A. Dahlberg, U. Adamson, R. Jansson and A. Karlsson (1991) Stressful life events and Graves' disease. Lancet 338 1475-1479.
61. D.C. Wraith, M. Goldman and P.H. Lambert (2003) Vaccination and autoimmune disease: what is the evidence? Lancet 362 1659-1666.